Awaiting product image

METIS G

Used In T2DM Patients

Glimepiride (Sulfonylurea): Stimulates pancreatic β-cells to increase insulin secretion (insulin secretagogue).

Metformin (Biguanide): Suppresses hepatic gluconeogenesis and improves peripheral insulin sensitivity (in muscle & adipose tissue).

Category: Tag:

Description

Glimepiride 1mg/2mg + Metformin PR 500mg

Used In T2DM Patients

Provides a synergistic approach—Glimepiride enhances insulin secretion, while Metformin suppresses hepatic glucose output and improves insulin sensitivity

Dosage: Available in oral tablet form. Once Daily

Related Products